Specialties

A new tool is developed to identify patients who are most at risk for chronic kidney disease (CKD).

Periodontal destruction can start very early in life in diabetes and becomes more prominent as children become adolescents.

Johns Hopkins brain scientists have hit on how and why some powerful drugs used for treating mental illnesses cause patients to gain so much weight that they often develop life-threatening complications such as diabetes and heart disease.

Preliminary results from a phase III withdrawal-design trial with lacosamide in patients with painful diabetic neuropathy show that lacosamide was statistically significant over placebo in reducing pain scores. SCHWARZ PHARMA plans for regulatory submission during the second half of 2007

Periodontitis — an infection of the gums that destroys the tissue and bone supporting the teeth — is associated with the development of kidney disease and end-state renal disease (ESRD) in patients with type 2 diabetes, doctors report.

According to new research from Wake Forest University School of Medicine and colleagues. Up until age 80, older adults not only gain fat as they age – but because of the obesity epidemic – they actually begin their older years fatter.

Periodontitis predicts development of overt nephropathy and ESRD in individuals with type 2 diabetes.

GW Pharmaceuticals announced preliminary results of two Phase III studies of Sativex®, its cannabinoid spray medicine, in peripheral neuropathic pain.

C-peptide improves sensory nerve function in type 1 diabetic patients with early-stage diabetic neuropathy.

Discovery can lead to treatment strategies for diabetic patients to protect them from kidney failure and may provide a marker to determine which diabetic patients are at increased risk for future kidney disease.